Track GANX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
GANX - Gain Therapeutics Inc (GANX) has a earnings per share of -$0.13, up 17.0% over the past year.
Latest EPS (Actual)
-$0.13
Beat Rate
62.5%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.16 | -$0.13 | Beat | +15.68% |
| Mar 2026 | -$0.14 | -$0.11 | Beat | +23.77% |
| Nov 2025 | -$0.15 | -$0.15 | Meet | +0.00% |
| Aug 2025 | -$0.17 | -$0.19 | Miss | -11.76% |
| May 2025 | -$0.18 | -$0.16 | Beat | +11.11% |
| Mar 2025 | -$0.19 | -$0.08 | Beat | +57.33% |
| Nov 2024 | -$0.21 | -$0.17 | Beat | +19.05% |
| Aug 2024 | -$0.20 | -$0.42 | Miss | -110.00% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.